These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16211843)

  • 21. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 24. [Strategy for empirical antibiotic therapy re-evaluation: do you have to change a successful therapy?].
    Veber B
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):654-7. PubMed ID: 15234739
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacoeconomical analysis of antibiotic use at the Clinic For Infectious Diseases of the Clinical Center of Vojvodina].
    Stefan-Mikić S; Jovanović J; Jovanović N; Sević S; Vukadinov J; Miucin-Vukadinović I
    Med Pregl; 2008; 61 Suppl 1():40-9. PubMed ID: 19248639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rational choice in the use of antibiotics in clinical practice].
    Gómez J; Ruiz J; Herrero F; Molina M; Baños V; Valdés M
    Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):214-20. PubMed ID: 8512975
    [No Abstract]   [Full Text] [Related]  

  • 27. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century.
    Paskovaty A; Pflomm JM; Myke N; Seo SK
    Int J Antimicrob Agents; 2005 Jan; 25(1):1-10. PubMed ID: 15620820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative antimicrobials: should we be concerned about antimicrobial drug use in equine surgical patients?
    Southwood LL
    Equine Vet J; 2014 May; 46(3):267-9. PubMed ID: 24716707
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focus on antibiotic stewardship. Introduction.
    Gould I
    Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S1. PubMed ID: 19596107
    [No Abstract]   [Full Text] [Related]  

  • 32. National antibiotic resistance surveillance and control.
    Raghunath D
    Indian J Med Microbiol; 2010; 28(3):189-90. PubMed ID: 20644302
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic resistance and the new plagues for the 21st century.
    Pulcini J
    Clin Excell Nurse Pract; 1999 May; 3(3):181-2. PubMed ID: 10646413
    [No Abstract]   [Full Text] [Related]  

  • 34. An infectious disease update on antibiotics: emerging resistance.
    Steinberg JS; Kim PJ; Abbruzzese MR
    Clin Podiatr Med Surg; 2007 Apr; 24(2):285-309. PubMed ID: 17430771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The era of the classical bacterial epidemics is over. Today the challenge is from the "Domestic Germs"].
    Heesemann J
    MMW Fortschr Med; 2005 Jan; 147(4):27-8. PubMed ID: 15745337
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 38. Utilization rate of carbapenems at intensive care units is not major determinant of gram-negative bacteria resistance to these antibiotics.
    Jankovic SM; Radonjic V
    J Infect; 2007 Nov; 55(5):480-1. PubMed ID: 17764746
    [No Abstract]   [Full Text] [Related]  

  • 39. Are broad-spectrum antibiotics the best choice?
    Harley NA
    Pa Med; 1994 Jun; 97(6):24-5. PubMed ID: 8065778
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotics versus resistant bacteria: a continual challenge.
    Kirst HA
    Expert Opin Ther Pat; 2010 Oct; 20(10):1271-2. PubMed ID: 20839928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.